No significant benefit seen for two doses when the age range was broadened to children younger than 9 years
FRIDAY, Oct. 17, 2025 (HealthDay News) — Receiving two doses of inactivated influenza vaccine (IIV) in the first year of influenza vaccination is associated with improved protection for children younger than 3 years versus one dose, according to a study published online Oct. 3 in JAMA Network Open.
Jessie J. Goldsmith, from University of Melbourne in Australia, and colleagues conducted a systematic literature review to estimate the increase in protection associated with the second dose of influenza vaccine for influenza vaccine-naive children younger than 9 years.
Based on 51 studies (415,050 participants), the researchers found that the pooled absolute increase in vaccine effectiveness of a second inactivated influenza vaccine dose in the first year of vaccination was 15 percentage points (pp) for those younger than 9 years (95 percent confidence interval [CI], −2.8 pp to 33 pp) and 28 pp (95 percent CI, 4.7 pp to 51 pp) for children younger than 3 years. It was not possible to assess the incremental benefit associated with a second dose of live attenuated influenza vaccine.
“Our findings suggest the second dose of inactivated influenza vaccine confers additional protection for influenza vaccine-naive children <3 years but that the benefit attenuates with age,” the authors write.
Updated COVID-19 Shot Beneficial for Those With Autoimmune Rheumatic Disease
AAP Issues Recommendations for Pediatric RSV Vaccination in 2026-2027 Season
Trends Reported in Vaccination Coverage for Adolescents for 2025
2005 to 2023 Saw More U.S. Women Never Screened for Cervical Cancer
Retinal Imaging Can ID Atrial Fibrillation Years Before Diagnosis
U.S. Adults May Not Understand Their Risk for Vascular Disease
Lower Breast, Cervical Cancer Screening Seen for Adults With Disabilities
Screening + Online Cognitive Behavioral Therapy Program Aids Nurses" Mental Health